$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses 원문보기

Biomaterials, v.273, 2021년, pp.120827 -   

Park, Hee Ho (Department of Biotechnology and Bioengineering, Kangwon National University) ,  Kim, Hyelim (College of Pharmacy, Chungnam National University) ,  Lee, Han Sol (College of Pharmacy, Chungnam National University) ,  Seo, Eun U (Brain Science Institute, Korea Institute of Science and Technology (KIST)) ,  Kim, Ji-Eun (College of Pharmacy, Chungnam National University) ,  Lee, Jee-Hyun (AREZ Co. Ltd.) ,  Mun, Yong-Hyeon (College of Pharmacy, Chungnam National University) ,  Yoo, So-Yeol (College of Pharmacy, Chungnam National University) ,  An, Jiseon (College of Pharmacy, Chungnam National University) ,  Yun, Mi-Young (Department of Beauty Science, Kwangju Women's University) ,  Kang, Nae-Won (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National Uni) ,  Kim, Dae-Duk ,  Na, Dong Hee ,  Hong, Kyung Soo ,  Jang, Jong Geol ,  Ahn, June Hong ,  Bae, Jong-Sup ,  Song, Gyu Yong ,  Lee, Jae-Young ,  Kim, Hong Nam ,  Lee, Wonhwa

Abstract AI-Helper 아이콘AI-Helper

Abstract The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on a global scale urges prompt and effective countermeasures. Recently, a study has reported that coronavirus disease-19 (COVID-19), the disease caused by SARS-CoV-2 infection, is associated with a decrease in...

Keyword

참고문헌 (85)

  1. 1 Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Zhang L. Fan G. Xu J. Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 10223 2020 497 506 31986264 

  2. 2 Vincent J.-L. Taccone F.S. Understanding pathways to death in patients with COVID-19 Lancet Respir Med 8 5 2020 430 432 32272081 

  3. 3 Danese S. Cecconi M. Spinelli A. Management of IBD during the COVID-19 outbreak: resetting clinical priorities Nat. Rev. Gastroenterol. Hepatol. 17 5 2020 253 255 32214232 

  4. 4 Jin Y.-H. Cai L. Cheng Z.-S. Cheng H. Deng T. Fan Y.-P. Fang C. Huang D. Huang L.-Q. Huang Q. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Mil Med Res 7 1 2020 4 32029004 

  5. 5 She J. Jiang J. Ye L. Hu L. Bai C. Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies Clin. Transl. Med. 9 1 2020 1 7 31907669 

  6. 6 Le T.T. Andreadakis Z. Kumar A. Roman R.G. Tollefsen S. Saville M. Mayhew S. The COVID-19 vaccine development landscape Nat. Rev. Drug Discov. 19 5 2020 305 306 32273591 

  7. 7 Hong K.S. Lee K.H. Chung J.H. Shin K.-C. Choi E.Y. Jin H.J. Jang J.G. Lee W. Ahn J.H. Clinical features and outcomes of 98 patients hospitalized with SARS-CoV-2 infection in Daegu, South Korea: a brief descriptive study Yonsei Med. J. 61 5 2020 431 32390367 

  8. 8 Jang J.G. Hur J. Choi E.Y. Hong K.S. Lee W. Ahn J.H. Prognostic factors for severe coronavirus disease 2019 in Daegu, Korea J. Kor. Med. Sci. 35 23 2020 

  9. 9 Zhang B. Zhou X. Qiu Y. Feng F. Feng J. Jia Y. Zhu H. Hu K. Liu J. Liu Z. Clinical Characteristics of 82 Death Cases with COVID-19 2020 MedRxiv 

  10. 10 Zaim S. Chong J.H. Sankaranarayanan V. Harky A. COVID-19 and multiorgan response Curr. Probl. Cardiol. 2020 100618 32439197 

  11. 11 Lee L.Y. Cazier J.B. Starkey T. Turnbull C. Kerr R. Middleton G. U.C.C.M.P. Team COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study Lancet 2020 1919 1926 32473682 

  12. 12 Mehra M.R. Desai S.S. Kuy S. Henry T.D. Patel A.N. Cardiovascular disease, drug therapy, and mortality in COVID-19 2020 N Engl J Med 

  13. 13 Shi S. Qin M. Shen B. Cai Y. Liu T. Yang F. Gong W. Liu X. Liang J. Zhao Q. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China JAMA Cardiol 2020 802 810 32211816 

  14. 14 Russell C.D. Millar J.E. Baillie J.K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury Lancet 395 10223 2020 473 475 32043983 

  15. 15 Geleris J. Sun Y. Platt J. Zucker J. Baldwin M. Hripcsak G. Labella A. Manson D. Kubin C. Barr R.G. Observational study of hydroxychloroquine in hospitalized patients with Covid-19 2020 N Engl J Med 

  16. 16 Mahase E. Covid-19: what Treatments Are Being Investigated? 2020 BMJ 

  17. 17 Zheng M. Gao Y. Wang G. Song G. Liu S. Sun D. Xu Y. Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients Cell. Mol. Immunol. 17 5 2020 533 535 32203188 

  18. 18 Grant W.B. Lahore H. McDonnell S.L. Baggerly C.A. French C.B. Aliano J.L. Bhattoa H.P. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths Nutrients 12 4 2020 988 32252338 

  19. 19 Riphagen S. Gomez X. Gonzalez-Martinez C. Wilkinson N. Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic Lancet 395 10237 2020 1607 1608 32386565 

  20. 20 Organization W.H. Clinical Management of Severe Acute Respiratory Infection when Novel Coronavirus ( nCoV) Infection Is Suspected: Interim Guidance, 25 January 2020 2020 World Health Organization 

  21. 21 Delaney J.W. Pinto R. Long J. Lamontagne F. Adhikari N.K. Kumar A. Marshall J.C. Cook D.J. Jouvet P. Ferguson N.D. The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness Crit. Care 20 1 2016 75 27036638 

  22. 22 Rodrigo C. Leonardi‐Bee J. Nguyen‐Van‐Tam J. Lim W.S. Corticosteroids as adjunctive therapy in the treatment of influenza Cochrane Database Syst. Rev. 3 2016 

  23. 23 Soy M. Keser G. Atagündüz P. Tabak F. Atagündüz I. Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment Clin. Rheumatol. 2020 1 

  24. 24 Stebbing J. Phelan A. Griffin I. Tucker C. Oechsle O. Smith D. Richardson P. COVID-19: combining antiviral and anti-inflammatory treatments Lancet Infect. Dis. 20 4 2020 400 402 32113509 

  25. 25 Rojas M. Rodríguez Y. Monsalve D.M. Acosta-Ampudia Y. Camacho B. Gallo J.E. Rojas-Villarraga A. Ramírez-Santana C. Díaz-Coronado J.C. Manrique R. Convalescent plasma in Covid-19: possible mechanisms of action Autoimmun. Rev. 2020 102554 32380316 

  26. 26 Anderson J. Schauer J. Bryant S. Graves C.R. The Use of Convalescent Plasma Therapy and Remdesivir in the Successful Management of a Critically Ill Obstetric Patient with Novel Coronavirus 2019 Infection: A Case Report 2020 Case Rep Women's Health e00221 

  27. 27 Shen C. Wang Z. Zhao F. Yang Y. Li J. Yuan J. Wang F. Li D. Yang M. Xing L. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma J. Am. Med. Assoc. 323 16 2020 1582 1589 

  28. 28 Valk S.J. Piechotta V. Chai K.L. Doree C. Monsef I. Wood E.M. Lamikanra A. Kimber C. McQuilten Z. So-Osman C. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a rapid review Cochrane Database Syst. Rev. 5 2020 

  29. 29 Lam F.W. Cruz M.A. Leung H.-C.E. Parikh K.S. Smith C.W. Rumbaut R.E. Histone induced platelet aggregation is inhibited by normal albumin Thromb. Res. 132 1 2013 69 76 23673386 

  30. 30 Ekaney M.L. Otto G.P. Sossdorf M. Sponholz C. Boehringer M. Loesche W. Rittirsch D. Wilharm A. Kurzai O. Bauer M. Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation Crit. Care 18 5 2014 543 25260379 

  31. 31 Xu J. Zhang X. Pelayo R. Monestier M. Ammollo C.T. Semeraro F. Taylor F.B. Esmon N.L. Lupu F. Esmon C.T. Extracellular histones are major mediators of death in sepsis Nat. Med. 15 11 2009 1318 1321 19855397 

  32. 32 Paik S. Choe J.H. Choi G.-E. Kim J.-E. Kim J.-M. Song G.Y. Jo E.-K. Rg6, a rare ginsenoside, inhibits systemic inflammation through the induction of interleukin-10 and microRNA-146a Sci. Rep. 9 1 2019 1 15 30626917 

  33. 33 Lee W. Ku S.-K. Kim J.-E. Cho S.-H. Song G.-Y. Bae J.-S. Inhibitory effects of protopanaxatriol type ginsenoside fraction (Rgx365) on particulate matter-induced pulmonary injury J. Toxicol. Environ. Health 82 5 2019 338 350 

  34. 34 Choi Y.H. Han H.-K. Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics J Pharm Investig 48 1 2018 43 60 

  35. 35 Hawkins M.J. Soon-Shiong P. Desai N. Protein nanoparticles as drug carriers in clinical medicine Adv. Drug Deliv. Rev. 60 8 2008 876 885 18423779 

  36. 36 Chen Q. Liu Z. Albumin carriers for cancer theranostics: a conventional platform with new promise Adv. Mater. 28 47 2016 10557 10566 27111654 

  37. 37 Chen Q. Wang X. Wang C. Feng L. Li Y. Liu Z. Drug-induced self-assembly of modified albumins as nano-theranostics for tumor-targeted combination therapy ACS Nano 9 5 2015 5223 5233 25950506 

  38. 38 Cortes J. Saura C. Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer Eur. J. Canc. 8 1 2010 1 10 

  39. 39 Chen T.-A. Tsao Y.-C. Chen A. Lo G.-H. Lin C.-K. Yu H.-C. Cheng L.-C. Hsu P.-I. Tsai W.-L. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis Scand. J. Gastroenterol. 44 5 2009 619 625 19191184 

  40. 40 Ashar H.K. Mueller N.C. Rudd J.M. Snider T.A. Achanta M. Prasanthi M. Pulavendran S. Thomas P.G. Ramachandran A. Malayer J.R. The role of extracellular histones in influenza virus pathogenesis Am. J. Pathol. 188 1 2018 135 148 29107075 

  41. 41 Høstmark A.T. Tomten S.E. Berg J.E. Serum albumin and blood pressure: a population-based, cross-sectional study J. Hypertens. 23 4 2005 725 730 15775775 

  42. 42 Singer M. Deutschman C.S. Seymour C.W. Shankar-Hari M. Annane D. Bauer M. Bellomo R. Bernard G.R. Chiche J.-D. Coopersmith C.M. The third international consensus definitions for sepsis and septic shock (Sepsis-3) J. Am. Med. Assoc. 315 8 2016 801 810 

  43. 43 Hazeldine J. Harris P. Chapple I.L. Grant M. Greenwood H. Livesey A. Sapey E. Lord J.M. Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals Aging Cell 13 4 2014 690 698 24779584 

  44. 44 Xu J. Zhou P. Wang W. Sun A. Guo F. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow J. Mol. Med. 92 1 2014 77 92 24042463 

  45. 45 Kim J.A. Kim H.N. Im S.K. Chung S. Kang J.Y. Choi N. Collagen-based brain microvasculature model in vitro using three-dimensional printed template Biomicrofluidics 9 2 2015 

  46. 46 Rittirsch D. Huber-Lang M.S. Flierl M.A. Ward P.A. Immunodesign of experimental sepsis by cecal ligation and puncture Nat. Protoc. 4 1 2009 31 36 19131954 

  47. 47 Sun F. Xiao G. Qu Z. Murine bronchoalveolar lavage Bio Protoc 7 10 2017 

  48. 48 Lee W. Seo J. Kwak S. Park E.J. Na D.H. Kim S. Lee Y.M. Kim I.S. Bae J.S. A double-chambered protein nanocage loaded with thrombin receptor agonist peptide (TRAP) and gamma-carboxyglutamic acid of protein C (PC-Gla) for sepsis treatment Adv. Mater. 27 42 2015 6637 6643 26414883 

  49. 49 Levi M. Thachil J. Iba T. Levy J.H. Coagulation abnormalities and thrombosis in patients with COVID-19 Lancet Haematol 7 6 2020 e438 32407672 

  50. 50 Jose R.J. Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation Lancet Respir Med 2020 e46 e47 32353251 

  51. 51 Barnes B.J. Adrover J.M. Baxter-Stoltzfus A. Borczuk A. Cools-Lartigue J. Crawford J.M. Daßler-Plenker J. Guerci P. Huynh C. Knight J.S. Targeting potential drivers of COVID-19: neutrophil extracellular traps J. Exp. Med. 217 6 2020 

  52. 52 Tay M.Z. Poh C.M. Rénia L. MacAry P.A. Ng L.F. The trinity of COVID-19: immunity, inflammation and intervention Nat. Rev. Immunol. 2020 1 12 31792373 

  53. 53 Fyodorov D.V. Zhou B.-R. Skoultchi A.I. Bai Y. Emerging roles of linker histones in regulating chromatin structure and function Nat Rev Mol 19 3 2018 192 

  54. 54 Barranco-Medina S. Pozzi N. Vogt A.D. Di Cera E. Histone H4 promotes prothrombin autoactivation J. Biol. Chem. 288 50 2013 35749 35757 24178300 

  55. 55 Lu N.-F. Jiang L. Zhu B. Yang D.-G. Zheng R.-Q. Shao J. Yuan J. Xi X.-M. Elevated plasma histone H4 levels are an important risk factor in the development of septic cardiomyopathy Balkan Med. J. 37 2 2020 72 31674172 

  56. 56 Vidali S. Morosetti D. Cossu E. Luisi M.L.E. Pancani S. Semeraro V. Consales G. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review ERJ Open Res 6 2 2020 

  57. 57 Yao Y. Cao J. Wang Q. Shi Q. Liu K. Luo Z. Chen X. Chen S. Yu K. Huang Z. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study J Intensive Care 8 1 2020 1 11 31908779 

  58. 58 Veras F.P. Pontelli M.C. Silva C.M. Toller-Kawahisa J.E. de Lima M. Nascimento D.C. Schneider A.H. Caetité D. Tavares L.A. Paiva I.M. SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology J. Exp. Med. 217 12 2020 

  59. 59 Skendros P. Mitsios A. Chrysanthopoulou A. Mastellos D.C. Metallidis S. Rafailidis P. Ntinopoulou M. Sertaridou E. Tsironidou V. Tsigalou C. Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis J. Clin. Invest. 130 11 2020 6151 6157 32759504 

  60. 60 Lee Y.Y. Park H.H. Park W. Kim H. Jang J.G. Hong K.S. Lee J.-Y. Seo H.S. Na D.H. Kim T.-H. Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm Biomaterials 267 2021 120389 33130319 

  61. 61 Arcanjo A. Logullo J. Menezes C.C.B. Giangiarulo T.C.d.S.C. Dos Reis M.C. de Castro G.M.M. da Silva Fontes Y. Todeschini A.R. Freire-de-Lima L. Decoté-Ricardo D. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19) Sci. Rep. 10 1 2020 1 11 31913322 

  62. 62 Vulliamy P. Gillespie S. Armstrong P.C. Allan H.E. Warner T.D. Brohi K. Histone H4 induces platelet ballooning and microparticle release during trauma hemorrhage Proc. Natl. Acad. Sci. U.S.A. 116 35 2019 17444 17449 31405966 

  63. 63 Hsieh I.-N. White M. Hoeksema M. Deluna X. Hartshorn K. Histone H4 potentiates neutrophil inflammatory responses to influenza A virus: down-modulation by H4 binding to C-reactive protein and Surfactant protein D PloS One 16 2 2021 e0247605 

  64. 64 Barbu E.A. Dominical V.M. Mendelsohn L. Thein S.L. Detection and quantification of histone H4 citrullination in early NETosis with image flow cytometry version 4 Front. Immunol. 11 2020 1335 32765493 

  65. 65 Vasques F. Duscio E. Romitti F. Pasticci I. Caironi P. Meessen J. Latini R. Cressoni M. Camporota L. Pesenti A. Septic shock-3 vs 2: an analysis of the ALBIOS study Crit. Care 22 1 2018 237 30261898 

  66. 66 Yin L. Dubovetsky D. Louzon-Lynch P. Implementation of an algorithm utilizing saline versus albumin for the treatment of intradialytic hypotension Ann. Pharmacother. 53 2 2019 159 164 30221974 

  67. 67 Kim D.H. Lee H.S. Kwon T.-W. Han Y.-M. Kang N.-W. Lee M.Y. Kim D.-D. Kim M.G. Lee J.-Y. Single enzyme nanoparticle, an effective tool for enzyme replacement therapy Arch Pharm. Res. (Seoul) 2020 1 21 

  68. 68 Mehtala J.G. Kulczar C. Lavan M. Knipp G. Wei A. Cys34-PEGylated human serum albumin for drug binding and delivery Bioconjugate Chem. 26 5 2015 941 949 

  69. 69 Butterfield J.T. Kim H. Knauer D.J. Nevala W.K. Markovic S.N. Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab Sci. Rep. 7 1 2017 1 9 28127051 

  70. 70 Chen Q. Chen J. Liang C. Feng L. Dong Z. Song X. Song G. Liu Z. Drug-induced co-assembly of albumin/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy J. Contr. Release 263 2017 79 89 

  71. 71 Suk J.S. Xu Q. Kim N. Hanes J. Ensign L.M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery Adv. Drug Deliv. Rev. 99 2016 28 51 26456916 

  72. 72 Schiel J.E. Ohnmacht C.M. Hage D.S. Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling Anal. Chem. 81 11 2009 4320 4333 19422253 

  73. 73 Daigo K. Takamatsu Y. Hamakubo T. The protective effect against extracellular histones afforded by long-pentraxin PTX3 as a regulator of NETs Front. Immunol. 7 2016 344 27656184 

  74. 74 Zhou F. Yu T. Du R. Fan G. Liu Y. Liu Z. Xiang J. Wang Y. Song B. Gu X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 2020 1054 1062 32171076 

  75. 75 Park H.H. Kim H.N. Kim H. Yoo Y. Choi E.Y. Bae J.-S. Lee W. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia Sci Adv 2020 eabc1564 32937590 

  76. 76 Mehta P. McAuley D.F. Brown M. Sanchez E. Tattersall R.S. Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression Lancet 395 10229 2020 1033 1034 32192578 

  77. 77 Liu Q. Zhou Y.-h. Yang Z.-q. The cytokine storm of severe influenza and development of immunomodulatory therapy Cell. Mol. Immunol. 13 1 2016 3 10 26189369 

  78. 78 Xiao H. Lu M. Lin T.Y. Chen Z. Chen G. Wang W.-C. Marin T. Shentu T.-p. Wen L. Gongol B. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility Circulation 128 6 2013 632 642 23838163 

  79. 79 Franchi L. Eigenbrod T. Muñoz-Planillo R. Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis Nat. Immunol. 10 3 2009 241 19221555 

  80. 80 Namiki M. Kawashima S. Yamashita T. Ozaki M. Hirase T. Ishida T. Inoue N. Hirata K.-i. Matsukawa A. Morishita R. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia Arterioscler. Thromb. Vasc. Biol. 22 1 2002 115 120 11788470 

  81. 81 Kusnadi A. Park S.H. Yuan R. Pannellini T. Giannopoulou E. Oliver D. Lu T. Park-Min K.H. Ivashkiv L.B. The cytokine TNF promotes transcription factor SREBP activity and binding to inflammatory genes to activate macrophages and limit tissue repair Immunity 51 2 2019 241 257 e9 31303399 

  82. 82 Tang J.J. Li J.G. Qi W. Qiu W.W. Li P.S. Li B.L. Song B.L. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques Cell Metabol. 13 1 2011 44 56 

  83. 83 Zhang Z. Tang Z. Farokhzad N. Chen T. Tao W. Sensitive, rapid, low-cost, and multiplexed COVID-19 monitoring by the wireless telemedicine platform Matter 3 6 2020 1818 1820 33289009 

  84. 84 Tang Z. Zhang X. Shu Y. Guo M. Zhang H. Tao W. Insights from nanotechnology in COVID-19 treatment Nano Today 36 2021 101019 33178330 

  85. 85 Tang Z. Kong N. Zhang X. Liu Y. Hu P. Mou S. Liljeström P. Shi J. Tan W. Kim J.S. A materials-science perspective on tackling COVID-19 Nat Rev Mater 5 11 2020 847 860 33078077 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD(Hybrid)

저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로